(National) Nov. 8, 2004 - Kyle Doyle, like as much as nine percent of America's children, has Attention Deficit Hyperactivity Disorder, "I won't listen, and I don't pay attention a lot, and I talk a ...
WASHINGTON - The FDA on Thursday approved the first skin patch to treat attention deficit hyperactivity disorder in children. Called Daytrana, the patch is designed to be worn for nine hours and ...
Four strengths of Daytrana prescription patches, worn to help children and adolescents diagnosed with ADHD, have been recalled nationwide by Noven Pharmaceuticals’ Miami office. The reason given on ...
NEW YORK (Reuters Health) - Smoking during pregnancy has been linked to a higher chance of the child having attention-deficit/hyperactivity disorder (ADHD), and a new ...
WASHINGTON - A federal advisory panel determined Friday that the first skin patch to treat attention deficit hyperactivity disorder in children is effective and safe, bringing it a step closer to ...
Daytrana (methylphenidate) is a prescription drug that’s used to treat attention deficit hyperactivity disorder (ADHD). It comes as a transdermal patch that’s usually applied to the skin once per day.
An article in the Philadelphia Inquirer on a new medicated patch for children with ADHD reports William Pelham, professor of psychology and pediatrics, conducted two trials of the patch. Go to article ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results